SupplyManager℠  Help

In-Office Lab Testing for Sexual Health

Are you offering same-day therapy for sexual health?

In-office lab testing for sexual health can help provide real-time results so you can diagnose and begin treating patients, now.

On-site lab diagnostics empowers primary care and community providers to more effectively help improve patient outcomes with a timely and accurate diagnosis. On-demand testing can support better guided clinical care, increased patient satisfaction and improved office efficiencies.

Do any of these sound like challenges you’re facing?

  • Clinical guidelines emphasizing clinicians to provide same day results and treatment
  • Slow time to results impacts treatment decisions and creates patient anxiety
  • Sending out testing represents further delay in diagnosis and treatment, risking community health implications; in addition, potential missed opportunity to capture reimbursable testing

Molecular Diagnostic Lab Testing for Sexual Health

Sexual health is a vital part of your patients’ overall health. When you screen for sexual health conditions at the point-of-care, you can help improve patient outcomes and satisfaction:

  • Discuss test results with patients while they’re still in your office
  • Begin treatment plans quickly
  • Improve patient compliance with a precise treatment plan

Conducting lab tests in your office is an easy way to help improve the quality of care. Today’s diagnostics offer options for a variety of specialties and conditions.

Gonorrhea and chlamydia are the two most commonly reported sexually transmitted infections (STI) in the United States.7 However, the true incidence of gonorrhea and chlamydia is difficult to estimate because most infections are undetected. In women, gonorrhea and chlamydia infections are most often asymptomatic but can cause cervicitis and complications of pelvic inflammatory disease (PID), ectopic pregnancy, infertility, and chronic pelvic pain.7, 8

We deliver the latest, cutting-edge laboratory and molecular testing available to produce the diagnostic results OB/GYN specialists absolutely require, helping to support patient outcomes and therapy.

Our comprehensive portfolio of testing platforms allows on-demand testing for:

  • Bacterial Vaginitis (microbial identification test)
  • Chlamydia trachomatis (CT), Neisseria gonorrhoeae (NG) and Trichomonas vaginalis (TV)
  • Group B strep (GBS)
  • Herpes simplex virus type 2 (HSV-2)
  • Cytomegalovirus (CMV)
  • Related testing: Respiratory Viruses including Influenza A+B, Strep and RSV

Sexual health is a key priority in men’s and student health centers. Sexually transmitted infections (STIs) affect sexually active people of all ages. But young Americans (ages 15-24) are especially hard-hit by the nation’s epidemic. While young people account for half of new STIs cases, only 12% were tested in the last year!5

On-demand laboratory testing for sexual health in men’s and student health centers allows healthcare providers to diagnosis and issue therapy/treatment in the same visit, helping to improve patient outcomes.

Our comprehensive portfolio of testing platforms allows for on-demand testing for sexually transmitted infections, including:

  • HSV 1+2
  • Chlamydia trachomatis (CT)
  • Neisseria gonorrhoeae (NG)
  • Trichomonas vaginalis (TV)

Additionally, our portfolio of molecular diagnostics also provides on-demand testing of respiratory viruses including Influenza A+B, Strep and RSV, as well as other key diagnostic tests.

In recent years, health centers served 25.9 million patients at over 10,400 urban and rural locations.9 Community health centers are a key component of our healthcare system, providing essential access to comprehensive primary care in under-served communities.

In serving the community, it’s vital to deliver comprehensive care while the patient is at the facility. This includes diagnosing on-site and outlining therapy for same day treatment.

To support urgent care and community health center providers, we deliver the latest, cutting-edge laboratory and molecular testing available to produce the diagnostic results healthcare providers absolutely require, helping to support patient outcomes and therapy.

Our comprehensive portfolio of testing platforms supports on-site testing for:

  • Sexually transmitted infections including:
    • HSV 1+2
    • Chlamydia trachomatis (CT)
    • Neisseria gonorrhoeae (NG)
    • Trichomonas vaginalis (TV)
  • Bacterial Vaginosis/Vaginitis
  • Group B strep (GBS)
  • Related testing: Respiratory Viruses including Influenza A+B, Strep and RSV

Point-of-care laboratory testing is integral to family practice and pediatric clinicians. Lab tests can detect diseases or conditions before signs and symptoms occur, allowing for treatment to begin sooner in some cases.

For sexual health testing, same day diagnosis supports same day treatment and therapy.

Our comprehensive portfolio of molecular testing platforms supports family medicine and pediatric providers to test on-demand for:

  • Sexually transmitted infections including:
    • HSV 1+2
    • Chlamydia trachomatis (CT)
    • Neisseria gonorrhoeae (NG)
    • Trichomonas vaginalis (TV)
  • Related testing: Respiratory Viruses including Influenza A+B, Strep and RSV

Laboratory Services

Laboratory Implementation Team

Our Laboratory Implementation Team helps with initial lab setup and implementation, ensuring you have enough space for lab equipment, verifying hazard protocols, validating and testing equipment and more. This team can help set up single pieces of lab equipment or help build an entire new lab. Email us today to get started.

Email us
Laboratory Specialists

Expanding or building your lab? Our team of laboratory specialists is available to help provide specialized consulting on various laboratory equipment and categories. Contact a laboratory specialist today. 

Email Us Today

1: Dr. Edward W. Hook, III Professor of Medicine and Epidemiology at the University of Alabama, Birmingham, and Director of the STD Control Program for the Jefferson County Department of Health.
2: Centers for Disease Control and Prevention. Sexually Transmitted Diseases in the United States. 2008.
3: Owusu-Edusei K, Jr, Chesson HW, Gift TL et al. The estimated direct medical cost of selected sexually transmitted infections in the United States, 2008. Sex Transm Dis. 2013;40(3):197-201. [PubMed]
4: Cates JR, Herndon NL, Schulz S L, Darroch JE. (2004). Our voices, our lives, our futures: Youth and sexually transmitted diseases. Chapel Hill, NC: University of North Carolina at Chapel Hill School of Journalism and Mass Communication.
5: Cuffe, Kendra M. et al. Sexually Transmitted Infection Testing Among Adolescents and Young Adults in the United States. Journal of Adolescent Health 2016, 58(5), 512-519.
6: CDC Fact Sheet: Reported STDs in the United States 2015 National Data for Chlamydia, Gonorrhea, and Syphilis.
7: Centers for Disease Control and Prevention. 2012 Sexually Transmitted Diseases Surveillance. Accessed at www.cdc.gov/std/stats12/toc.htm
8: Centers for Disease Control and Prevention (CDC). CDC Grand Rounds: Chlamydia prevention: challenges and strategies for reducing disease burden and sequelae. MMWR Morb Mortal Wkly Rep. 2011;60:370-3. [PMID: 21451447]
9: GW and Kaiser Family Foundation analysis of 2009 and 2014 Health Center Patient Survey Data.


Request a complimentary consultation with a Lab Specialist today.